Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Menstruation Disturbances 1Hyperandrogenism 1

Interventions

Metformin 41Clomiphene 17Letrozole 6Menotropins 5Folic Acid 5drospirenone and ethinyl estradiol combination 4Liraglutide 4Chorionic Gonadotropin 4cetrorelix 3Triptorelin Pamoate 3Progesterone 3Pioglitazone 3Leuprolide 3Inositol 3Exenatide 3Ethinyl Estradiol 3Estradiol 3Vitamins 2Sperm Injections, Intracytoplasmic 2Sitagliptin Phosphate 2Simvastatin 2Gonadotropins 2Glycoprotein Hormones, alpha Subunit 2Exercise 2Escitalopram 2Cyproterone acetate, ethinyl estradiol drug combination 2Contraceptives, Oral 2Cholecalciferol 2Carnitine 2Canagliflozin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Polycystic Ovary Syndrome × Cyproterone acetate, ethinyl estradiol drug combination × Clear all
NCT02866786 2018-04-20

The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

S.C.B. Medical College and Hospital

Phase 4 Completed
101 enrolled

Polycystic Ovary Syndrome

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡